https://scholars.lib.ntu.edu.tw/handle/123456789/641593
標題: | Association between treatment-emergent hypertension and survival with lenvatinib treatment for patients with hepatocellular carcinoma in the REFLECT study | 作者: | Piscaglia, Fabio Ikeda, Kenji ANN-LII CHENG Kudo, Masatoshi Ikeda, Masafumi Breder, Valery Ryoo, Baek-Yeol Mody, Kalgi Ren, Min Ramji, Zahra Sung, Max W |
關鍵字: | hepatocellular carcinoma; hypertension; lenvatinib; prognosis; statins; treatment outcome | 公開日期: | 15-四月-2024 | 卷: | 130 | 期: | 8 | 來源出版物: | Cancer | 摘要: | Lenvatinib is approved as a first-line treatment for patients with unresectable and/or recurrent hepatocellular carcinoma (HCC). Lenvatinib achieved promising clinical benefits in REFLECT but was associated with clinically significant treatment-emergent hypertension (CSTE-HTN, a grouped term), a common class effect of tyrosine kinase inhibitors. This post hoc analysis assessed the impact of CSTE-HTN on the efficacy and safety of lenvatinib in HCC. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/641593 | ISSN: | 0008543X | DOI: | 10.1002/cncr.35185 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。